Insiders · PCSA

David Young

Pres. Research & Development, Director at Processa Pharmaceuticals, Inc. (PCSA)

David Young has filed 37 insider reports with the SEC since June 2021, as pres. Research & Development and director at Processa Pharmaceuticals, Inc. (PCSA). In the last 12 months David Young bought $32.4K of stock on the open market. In the latest filing, on July 1, 2026, David Young bought 2,531 shares of Processa Pharmaceuticals, Inc. (PCSA) for $4,885 at an average of $1.93.

Filings
37
Companies
1
Bought on market
$382K
Sold on market
None

Companies where David Young is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Processa Pharmaceuticals, Inc. logo
PCSA
Processa Pharmaceuticals, Inc.
Pres. Research & Development, Director21,729$382K$1.24$1.69+36%Jul 1, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare David Young with

Other insiders at the same companies

Questions about David Young

What is David Young's role at Processa Pharmaceuticals, Inc.?
David Young reports to the SEC as pres. Research & Development and director at Processa Pharmaceuticals, Inc. (PCSA), according to the latest filing on July 1, 2026.
How many shares does David Young own?
After the latest filing that states it, David Young directly owned 21,729 shares of Processa Pharmaceuticals, Inc. (PCSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Young bought or sold stock recently?
The most recent open-market purchase was on June 30, 2026: bought 2,531 shares of Processa Pharmaceuticals, Inc. (PCSA) for $4,885 at an average of $1.93.
How do I get alerts when David Young files?
Follow David Young on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Young (SEC CIK 0001378166). Totals count each trade once, skipping amendments whose original is on file, from Jun 10, 2021 on. View on SEC EDGAR · Get this as JSON